Table 3.
Subjects | n | PCOOH (nmol/L)a | P | |
---|---|---|---|---|
vs controls | vs normalized | |||
Controls | 47 | 160 ± 65 | ||
Hyperlipidemia | ||||
Normalized | 13 | 202 ± 17 | NSb | |
Type IIa | 34 | 322 ± 32 | <0.05 | <0.01 |
Type IIb | 24 | 353 ± 28 | <0.01 | <0.01 |
Type IV | 23 | 397 ± 48 | <0.01 | <0.001 |
aMean ± SE.
bNS, not significant.
Adapted with permission from Ref. 70. Copyright 2000 Oxford University Press.